"Retina & Vitreous of Texas is a Houston, Texas, vitreoretinal care clinic. Our physicians and staff are dedicated to providing the best medical, surgical, and laser retina and vitreous care possible. Make an appointment with us for total care within a user-friendly atmosphere that is conducive to innovation, research, and cutting-edge technological advances."

During the past decade, Retina and Vitreous of Texas conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina and Vitreous of Texas" #1 sponsor was "Jaeb Center for Health Research" with 13 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Aerpio Therapeutics" with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Clearside Biomedical, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina and Vitreous of Texas" #1 collaborator was "National Eye Institute (NEI)" with 15 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Allergan" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 3 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Retina and Vitreous of Texas" are "Diabetic Macular Edema" (13 trials), "Diabetic Retinopathy" (6 trials), "Proliferative Diabetic Retinopathy" (4 trials), "Macular Edema" (3 trials) and "Central Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "Retina and Vitreous of Texas" in a lesser frequency.

Most popular intervention types in "Retina and Vitreous of Texas" are "Drug" (24 trials), "Procedure" (11 trials), "Other" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Ranibizumab" (3 trials) and "Deferred aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina and Vitreous of Texas" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Retina and Vitreous of Texas". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Retina and Vitreous of Texas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina and Vitreous of Texas, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".